Does GARENOXACIN Cause Interstitial lung disease? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Interstitial lung disease have been filed in association with GARENOXACIN. This represents 14.8% of all adverse event reports for GARENOXACIN.
13
Reports of Interstitial lung disease with GARENOXACIN
14.8%
of all GARENOXACIN reports
3
Deaths
10
Hospitalizations
How Dangerous Is Interstitial lung disease From GARENOXACIN?
Of the 13 reports, 3 (23.1%) resulted in death, 10 (76.9%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GARENOXACIN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does GARENOXACIN Cause?
Hepatic function abnormal (12)
Pyrexia (10)
Pneumonia (9)
Agranulocytosis (6)
Rash (6)
Decreased appetite (5)
Drug-induced liver injury (5)
Drug ineffective (5)
Tubulointerstitial nephritis (5)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)